Multiyear, real-world, retrospective cohort study using a patient-centric approach to evaluate the burden of haemophilia B in the United States

Haemophilia. 2024 Sep;30(5):1234-1237. doi: 10.1111/hae.15077. Epub 2024 Jul 22.

Authors

Arianna Burton¹, Yong Chen², Priya Patel¹, Jose Alvir³, Darren Kailung Jeng³, Anna Stachel Kane², Jiayin Xue⁴, Emily Cibelli⁴, Patrick F Fogarty⁵

Affiliations

¹ Medical Affairs, Pfizer Inc, New York, New York, USA.
² Medical Affairs, Real World Evidence Center of Excellence, Pfizer Inc, Collegeville, Pennsylvania, USA.
³ Global Product Development, Pfizer Inc, New York, New York, USA.
⁴ PicnicHealth, San Francisco, California, USA.
⁵ Medical Affairs, Pfizer Inc, Collegeville, Pennsylvania, USA.

PMID: 39037889
DOI: 10.1111/hae.15077

No abstract available

Publication types

Letter

Grants and funding

Pfizer